The methylimidazolium ionic liquid M8OI is a substrate for OCT1 and p-glycoprotein-1 in rat

Shireen Hedya1, Alex Charlton2, Alistair C Leitch3

  • 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt; Institute of Translation and Clinical Research, Newcastle University, Newcastle Upon Tyne NE2 4AA, United Kingdom.

Insights

Methylimidazolium ionic liquid M8OI shows toxicity in rats. Its toxicity is linked to p-glycoprotein-1 (P-gp) transporter expression, with higher P-gp levels reducing M8OI

Area of Science:

  • Environmental toxicology
  • Pharmacokinetics
  • Cell biology

Background:

  • Methylimidazolium ionic liquid (M8OI) has been detected in the environment and humans.
  • Understanding M8OI's toxicological impact and disposition is crucial.

Purpose of the Study:

  • To investigate the disposition and toxicity of M8OI in a rat progenitor-hepatocyte model.
  • To identify the cellular mechanisms underlying M8OI's toxicity.

Main Methods:

  • Utilized a rat progenitor-hepatocyte model (B-13 and B-13/H cells).
  • Assessed M8OI toxicity with and without inhibitors/substrates of organic cation transporters (OCTs) and p-glycoprotein-1 (P-gp).
  • Quantified transporter expression at transcript and protein levels.

Main Results:

  • Progenitor B-13 cells were significantly more sensitive to M8OI than hepatocyte B-13/H cells.
  • M8OI toxicity in B-13 cells was reduced by an OCT1 inhibitor but unaffected by OCT2/3 inhibitors.
  • M8OI toxicity was increased by P-gp substrates/inhibitors, and M8OI inhibited P-gp substrate excretion.
  • Higher P-gp-1 expression in B-13/H cells correlated with lower M8OI sensitivity.

Conclusions:

  • M8OI toxicity in rats is significantly influenced by the expression and activity of the p-glycoprotein-1 transporter.
  • P-gp-1 plays a key role in mediating M8OI disposition and mitigating its toxic effects.

Related Concept Videos